AbbVie Inc. (ABBV)

AbbVie Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	54,403	54,318	58,054	56,197	45,804	33,266
Revenue Growth (YoY)	-4.12%	-6.44%	3.30%	22.69%	37.69%	1.57%
Cost of Revenue	20,523	20,415	17,414	17,446	15,387	7,439
Gross Profit	33,880	33,903	40,640	38,751	30,417	25,827
Selling, General & Admin	13,148	12,872	15,260	12,349	11,299	6,942
Research & Development	7,322	7,675	6,510	6,922	6,379	6,407
Other Operating Expenses	623	599	753	1,556	1,376	-505
Operating Expenses	21,093	21,146	22,523	20,827	19,054	12,844
Operating Income	12,787	12,757	18,117	17,924	11,363	12,983
Interest Expense / Income	1,683	1,684	2,044	2,384	2,280	1,509
Other Expense / Income	3,585	4,833	2,605	2,558	5,691	3,048
Pretax Income	7,519	6,240	13,468	12,982	3,392	8,426
Income Tax	1,526	1,377	1,632	1,440	-1,224	544
Net Income	5,993	4,863	11,836	11,542	4,616	7,882
Net Income Growth	-20.99%	-58.91%	2.55%	150.04%	-41.44%	38.60%
Shares Outstanding (Basic)	1,769	1,768	1,771	1,770	1,667	1,481
Shares Outstanding (Diluted)	1,773	1,773	1,778	1,777	1,673	1,484
Shares Change	-0.17%	-0.28%	0.06%	6.22%	12.74%	-4.01%
EPS (Basic)	3.37	2.73	6.65	6.48	2.73	5.30
EPS (Diluted)	3.37	2.72	6.63	6.45	2.72	5.28
EPS Growth	-20.52%	-58.97%	2.79%	137.13%	-48.48%	44.26%
Free Cash Flow	21,891	22,062	24,248	21,990	16,790	12,772
Free Cash Flow Per Share	12.38	12.48	13.69	12.42	10.07	8.62
Dividend Per Share	5.990	5.920	5.640	5.200	4.720	4.280
Dividend Growth	4.90%	4.96%	8.46%	10.17%	10.28%	19.22%
Gross Margin	62.28%	62.42%	70.00%	68.96%	66.41%	77.64%
Operating Margin	23.50%	23.49%	31.21%	31.89%	24.81%	39.03%
Profit Margin	11.02%	8.95%	20.39%	20.54%	10.08%	23.69%
Free Cash Flow Margin	40.24%	40.62%	41.77%	39.13%	36.66%	38.39%
Effective Tax Rate	20.30%	22.07%	12.12%	11.09%	-36.08%	6.46%
EBITDA	17,847	16,622	23,979	23,887	12,143	11,952
EBITDA Margin	32.81%	30.60%	41.30%	42.51%	26.51%	35.93%
Depreciation & Amortization	8,645	8,698	8,467	8,521	6,471	2,017
EBIT	9,202	7,924	15,512	15,366	5,672	9,935
EBIT Margin	16.91%	14.59%	26.72%	27.34%	12.38%	29.87%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).